!" #$
% &'(
) * +
+
,
+ +
- .
- .
+ , +
+
+ +
+
+
+
+
+
+
+
+
- . + +
+
+
+
+ + /01 234567869:
3 <=3>?6 @ AB CDEF ;
G H IJ6K LMNO PQ R S5B T 3U S6 4A 2 HFG VWXYZ R [S6 LMNO PQ R \ A ]^ _ ` ^aGH \ A >b
^ cdGe # `f?: ]Hg ^h iIJ j 3 aGCDA k= J: ]AT ^ : AB H [l?:m^3>b mJ=` n ` ?: ]AT EFG %U 9op: ] Hq IJ !"U A A LMNO PQ R EFG
k= r d st u^ [Av` 1w 8G xVWXYZ R EFG y%U@z{H 3|?: } E ~ A ]` aGm^3> Ej rIJ: R H[A 3F:G n G ] x dA Hg 3 ` ?: ]AT `78: ^S
=k^d?61: U cSxaw mJ` a 6A 3U O PQ 3 aG
G:3U Y`w 4 HFb Y d
`w 4:3U H dw6a9 HFG KUQ Hd5 [A:
H 5 EFGm^H=JG 4b R Ae "UmJ=A 3S mA 4A U53 d`f?6 S6 6[A # ` RaGk H# ` aG 5G @zEU mJ=A ` S: AO P :3 e aG ^A` RaGm^` ?:
Q R xVWXYZ R HT IJG^^j3 ]T 3dG %A ^S6U # R HF XZx #$` ^S: S5 G y%U e ¡Hk¢£ B jh iIJ A E IJG>¤3 3>?6I=3 43 IJG e ¡ d?: mA>¤3 ¥3 S: AFGB i H A ^S6
EFGH \ A 3 Cd H S dHFG } e ¡H¢£
:^S6j [J3 aG ] A ` A ^S6 E1d5^¦oJG 4b T ^ A
5o§G 5:¨©?m U A w^¦oJG [ dHFG R Umm3 mE ª«¬EU S5YVW3®¯w IJG mJ=A e U 3^?6
A`X°^S6 mA 356 3 EFG: e R 3U dB CD
`±?65G²³% 3 [J´JA H E1G : A ]^e "Hcd D3456 `S6 1 mJk=AB A G: \ A ]3 aG 3jCDH
E1G R A µ`*¶6 ·yA n T U^¢£¸A e
` ¨ G>¤d ]AT 32k¤m^H IJG Ej¢£ 3aG R uA U5 ¹ ºkb ; » h¼ ½
!
" # $ % &
'( ) * +, - . / 0 ! 1
. , . 2 * +, 3 . ' 45 3 .
. 6 7 . 6 81 9 : ; . /
<= . > ? - 45 @ . / A -B
C D6E F G 2 * +, .
H I1 J , .
! . K 6 L , . GMN -
C 81 > K O1 PQ R 45 @ . / 45
S J , T * + U
V. W XY
W V. = Z + 1
K O1 [ . , . 6 45
PQ: \] 3 H , 45 H /
: ^ -BG * _ 6 , @
+, . , . / . / A N H, .
`a 45 - _ 6 T
. 6 bc 6 d _ 6
e f T N
E 3 81 g -. h ! _ 6
9 . 81 / , T N -. / 81
i j , . d
k - _ 6 <l X
E " mn5 o _ 6, . pq5
r e s . 6
/M t . 3 . 9 81 s
, . bc5e -
. / _ 6
u v . / wx
y T , . s
yz { | " # k } ~
! "
#$%& '()*+,-.
ῌ
῍ ῍ ῍
The Japanese Society for AIDS Research The Journal of AIDS Research
Experimental Retrovirology Section, Medicine Branch, NCI, NIH, USA,
:
HIV
zidovudine HIV
HIV
etravirine TMC darnavir,
CCR
HIV RNase
H Env, Gag, Tat, Rev, Vpr, Nef, Vpu, Vif RNase H
Env
HIV
HIV Gag-Gag, Tat-TAR,
Rev-RRE
Env-CCR , Env-CD , Gag-Tsg , Tat-Cyclin T , (CycT ), Rev-CRM , Vpu-Tetherin/BST- ,
Vif-APOBEC G/F CCR
HIV
HIV
CCR HIV
, , , ,
Masanori BABA Hirotomo NAKATA Kaori ASAMITSU Atsushi KOMANO Mika OKAMOTO and Wataru SUGIURA
HIV
HIV
Perspectives of Anti-HIV Research
,*+*
+ ,
-
. /
+ , - . + /
+ , - .
+ /
23* 2/.. 2 -/ +
,*+* . +3 +32/
,
+,/
/
,
,
/ . +*+
+ + + ,
- /
.
/ ,
,--
ῌ
!
" # $ %& ' %
,-.-/012-3 ()*+
4+ 56789 56789: ; " <= >!?@
ABC- DEF 3 G /012- HI JK L !EL " M ' ; N:ABC- O PBQRS-T < + UV 3WXEL V YZ[ "89R\] T >! < X
^ < _ ` a EL D)D< b! "c8d,O
>! e>!f " ; DELI c8d, J b<
g hiDE ) jk lm nIo p f) q DE rp
<>!EL D)D< ,Rs F& W^ <t !EL<J B * u WLE" ) obv < DI< BQc8d,) w XELL < L v "3S1xy z i { ]8/|8}d w i ; < ~ % { L ) ) b! LE % % <[ >!M n!I
' J> Iu p DI b BQc8d,) { b<l
! u ; > % M " c8d, "M O J <u ; W XEI >!Iw
b ; * " !L< BQc8d,) {
I nm % J> Iu "c8d,w " >!I JDEL nI" ; b { <c8d, bBQ f g<) v ; c8d, ) " hi c
" < 8d, hi p + >
JDELu " ; " q !E*+ b! hi + ":Qc8d DELb<)XI ob J:d< ,DE" lE c8d, <>!
D ; <@ >! oZ " PL u L % % J ¡ ¢P Y J< XEL
> u ; <f
) I oZ Lm! % L BQc8d,) DI^
I [ % J £ Lu I [ iDEH !" ¤ ; ~< !I ; ~" + o!¥!
% <¦ >!EL u §b<l b! DI
¨>! ; ~" % © DE Jª + p
" % J £ «hDEL ¬©b<lb w i { !I % < Vn C-sDELI c8d, J
£ % < ¦ >!ELE ; b<lb<H ! g
< % J> Iu DE" ®[ < !ELLb n ~b< )XI b! ; Z gDE" p < ¯ II
u b v " D°D° p < b<H ! v g ± < b ) " b! WLE jk D 6²d ³ ªXEL< ´"~ WLE µ 6²d¶ DI ·6²d ;
6²d DI "c8d, l ¸°!
p JF WLE¹ ªXI ,Rº »d¼ d-B& )
½# !I " ; * ' [ ± D w i
! "# $ % &
' () * + (,
- ./ 01
% 2 34 %4 % +
5 67 01 8 9: ; <
= >) ?( @ AB >C D E F
GH I % J
K LM N OP Q
RS T U VW X Q
: Y Z [\ ] VW X ^
!_ ] ] `a b &* c d
@ ef g b &* : X S
g h : ] &* c &* +
ef g : i S Qjkl
m LM n Vo &* X
`a g Qjkl pq Vo
r r : &* X st uvc
w m x &* ?(y&*
zS . {|&* : }~
g : ( r &*
Tl a
7|!X : rz @ : Q:
[ g ] `a ?( % 9: ;
ef ] g : ]
m ] &* 8
] ef V g 8S .
: Z 5 : Z _
`a r I . g 8
: Z `a r D
] ef V Q VW X
] ef V % 9: ;
`a r zS I <
: ] g !X
Z S x T
K sr D
i b ) 6
7 %
r )
r _
LM s b Q &*¡
ῌ
῍
῎
ῌ ῌ
,
CCR
CCR G G-
protein coupled receptor : GPCR
CC HIV HAART
GPCR
CXCR HIV
HIV CCR
HIV maraviroc FDA
CCR HIV
HIV HIV
CCR HIV
HIV HIV HIV
CCR HIV-RNA DNA
CCR DNA HIV
CCR
CCR HIV RNA
CCR HIV RNase H
HIV CCR HIV
CCR
CD CCR HIV
DNA NF- B
CCR ABS ABS : antibody binding site Tat
HIV CD HIV
CD
HIV HIV
CCR CCR
HIV
CCR HIV HIV
CCR Tat
HIV HIV NF- B Tat NF- B
CCR ABS
CCR HAART
CCR
CCR
CCR Tat
CCR
NF- B NF- B
HIV
CCR cluster Tat NF- B
CCR cluster CCR cluster Tat
HIV
CCR CCR cluster CCR Tat mRNA TAR
CycT CDK
HIV CCR P-TEFb HIV
HIV CCR
HIV
+ ,
-
.
.
/
/ 1
.
/
/
/
. /
/ /
/ /
/ /
. /
/ +*
. .
/ /
/ /
/ +*
/ +
/ ,
/ /*
/ /
+ /
/ , /
/ - / / /
+ 3
+ /
1/ +1
/
k
k k
k k
k
!" #$%&' ()*+, -.#/0 1234 &56'
#789: !; #<=&'
& &>?#@A #BC) DEFG@A 1204
H IJK.LM
N & OPQ &&R
3ST@A &789' UVWIJXK.L
&78YZQ[\]^ _' &
78X<=0YN' N &78Y Z`' abc UVWIJXK.LYZQ[
ῌ
ῌ CCR
HIV CCR CCR cluster
CCR
CCR cluster CCR
CCR gp HIV
Tat HIV LTR
A Tat CycT CDK P-TEFb HIV LTR
TAR HIV
B Tat CycT Tat CycT
Tat TAR HIV
/
/ /
/
/ /
/ +,*
+ 3
+ +
+
,
d efghi jGklXm%9:
*+YN' Hnop
@A: q r# st 78u&Hn #
9c #vw
@A opXxy
ῌ
ῌ
ῌ
ῌ MazF HIV
MazF HIV
Tat TAR
MazF HIV mRNA HIV
+
,
-
-
! " #
$%&$ '() "
! " *#
$%&$ +, "
-. ! " *#
$%&$ +, "
/0123)4 5 6 7 89:; : <=> ?@A BCADEF ;
GHIJ KLM 2NO 6 K PQR% C@STUV%W:
: XLNYZ# L G[72<\ ] ^ _`DE 2N _`a bc d 2<A 5 ; : "C@A @-.! :eA@ f ; G[7:gOh@ ijJGA? kl6Gm _`DEG;-.
6[7 n2< oLp 2<JI qr s C PQR%:tuA@ -.!
GC@v 6GLw 2< ]62 G[ "/01 xjyG<:Z%1 : ?=>
7: 2N z{| } GC fDE~ C
:gO G v PQR% GZ%1z{|[7
GCr p 6GGC " G; GAlm 2' 3)47 @O jc k@A @DE 2 6G; 2NL ]'
d GCBr p 6 Cee _`DE:gB G:gO Z%1 :" o : G
)Z%1" 2<c\ Cgl
bcZ%13)4 q G6GLw _`DE; )! " #G!
jJ * "# : jJ )! "
#; @-.! : } C 'e\e : C Z%1 %{.
f 2N 6P A@
¡ :r/.Z%1 p ; ¢ £ ! STUV%W: fC ¤:Cp DEG B L¥ eDE1bc jJ ]J¦J
DE kC@kl LN ¡ GC@
6Jt:C@§¨ § ¨ r/.Z%1 C@A ]Jc; no £ : p C@A©2N ¢ :D ª u«cJ 6JcDE[¬; ¡ v E; :®O 662;B ¯DE: °: ©± ²cC@©J
³ @ CbC ² ?I e ´
¥ -. STUL cbGO µDE ! ©;M C@AA ¶ : LgO' ·y STUV%W DEF ¸GjJ¢ ¡L¹¶J@AA 6º L9»C@< 6J;B DE 'eGC@~ jJ@A;¼½Gs jJ
! " #
$
% & '
& (
) * + , -.# /
0
, & $ 1 "
2 3 4 5 67 8
, & 9
: ; & < = > ?&, @AB CD EF
% GH =
' % I
( J I
" K L
M
N # O
, & P # QR
S K T U
?& , V ) WX
& % ?& , P
S ?& , Y 0
Z ?& , "D [ \ ]
B 5 @AB ^ ]
T " _ `2 \ )
a b 67 S
?& , c
ῌ
ῌ
A HIV
CycT TRM
CycT Tat
HIV-LTR B Tat
CycT
HIV cell-based
Tat
CycT two-hybrid
in silico CycT Tat
HIV
HIV HIV
HIV
siRNA shRNA
HIV
HIV
HIV HIV
HIV
HIV HIV
HIV-
siRNA shRNA Zhou et al., Cell Host Microbe
Brass et al., Science Konig et al., Cell
cDNA Stremlau et al., Nature
Valente et al., Mol Cell Valente et al., PNAS T
cDNA Kawano et al, J Virol
Yoshida et al., Tra c Urano et al., FEBS Let Urano et al., Vaccine, in press
.
/ 1
2
, +
+
, +
+
+
+
,
- +**
-
+
,**2 ,**2
,**2
,**.
,**0 ,**3
,**.
$ ,**2 ,**2
11 +3
+
ῌ
ῌ
!"# $% & '()*+,- . /01 23456 789) & :6;<*- =">, ?
@ ABC D)E)FGH I J"KLMN ?OPQ A R S D)NTU6 V6W X ' U& Y45 Y
NZ3),O+, N& 6A*936[\N *];O ^ S 6 ; U6 & N _6S` U& aN `)b 6Q )b3,O - A' 9)* Nc S*SBOde +, 6fg h
& & U& & N ,U ^ &
+ i,S*^ U ML!"jkl' 6
& 1=mno & S* +;O a23 F 6I J"
,@ D & 3)FGHR KLM6 S* _pq & :,[P & 6r*T2Ns* t 3) S2S pq & :NI J"KLM6 U 6A*uO t9) ' S*lo"1 v-w
xO2 6;01="> FG y6 Nz{"U6u;O|
6' U& 6 3), t S*2N[P*];O N}A~
& , & 1= & L" N' S0 mno@ 6 ? S**- 1="> N $9+, + o YI ?,3 )6 S !" k`
. /01=">6; Y U+,6;C U+,
. - 3)R,# 6@ NU
S*+,(2 N[P }AoM
h / ,S* -Q , D /
N}A~ & L"N S hAA k +
& 6 S* oM kLqN tU !"6;|
^ 6 Ui Y 01="> ~ & L"6 +;O 9) 01=">N
6 S*S ;C ,S 45 Y-HRN 78U
* & !"N - h Y& u!MLN O /6 9) +| oM @ 2 6 N U !" 23 N - YU h ¡V Y & 6N
N S* U oM¢ , P X£oM N t o S* 9)+| R M N @ 6 YUI N 3)¤ ¥ I ML!"jkl6;<* !"23 q=oM ,S* &
¦ N U| 6N P6oM N U~O§BS
!" # ¨© u ª<* N «U)b ¡V
!" U& 6;<*FGHR 7 Y ;C S*,[P3) 89)+, Pb ¬ & 23 3) +)3 *N®S ¯ !"N¡
!"N° 6' U)b V 6 9pq & :N± S* D& 23 Y,S* N²³U+, ¤ -O Y N<* ¡V hA +| ´ 6hµC¦ N U6 q=oML" k>
¶9)+, +) oML"6;C !"N& 6
· c¸9)*SBO S* !"6;{0MN¹$U de +)3 6- ) 6 !"N' S
¤ B ¦ ,S* 9) N· -c 96 º#N P¦
2< , »¼2-W 6 t ¶9);O½ -<* ¯ +
!
"# $ %& '
( )* + , -./
0 1 2
%& 34)* 5 6 78 ' '
6 9 +
: 9 (
6 ;
< => ; ?
!
@ ; A 9 BC D
6
E ) &
(
34 BC
# FG HI J K : ! LM -
. NO P
5 Q B BC RS T Q
D U VWNO VW X
34 ; 5 A
A ' ( Y H BC D
5A # ! Z
( Q T 5A
[D \ ]
/ A 34 ^ _N `
a 34 b 5 )*
cd # e f 34 ;
# A 78 g 34 ^ / :
. -./ L
h # A i f 34
j k C -. # l
m& no 5 9
Q : B
p 34 q
r 34 #
A h sg
t ^u H vs
I abw
a Z -./ 3x !
y# h cd / 1 Z f h
34 z ; t {
,
,
,
siRNA shRNA mRNA siRNA shRNA
siRNA shRNA HIV
HIV CD T HIV
HIV
CD T
T
CD T T
siRNA shRNA
ORF
CD T siRNA shRNA
cDNA
HIV ORF
hnRNP U N
ORF Brd C
cDNA siRNA shRNA
HSV- STING ORF
HIV
cDNA
cDNA HIV
CXCR
cDNA
cDNA complexity, cDNA
CD cDNA
cDNA HIV T
CD HIV
cDNA cDNA
cDNA
HIV
+, +-
3 +*
++
+- +.
-
-
.
.
.
.
.
+
.
.
.
ῌ ῌ
ῌ
ῌ
ῌ
ῌ
ῌ
!"# $% &'
() *+,-# ." / 012 23'
&' 324 5 6768 89:$;3 $<
#= &' >?4 @3$($ 34A BC D D#EF'
>?GHIJ >? # KL (<- DLM & &$N # &' @2
# &$ 6768O I P D &< QRSTUV # WX STUY Z[ D\] &' &1& B , # ^ L_ 4 \`a4(1b'
($ Bc( d ( -e & 4] , f g$123
$ *+, @3$#hi jkl ] , )m2 $<
A 4 d ( # i' - n 4o -b' &1& 4 f pq3 32 N , r < dLsC L_ -'
&t g$1# L'F>?# u$R F #sC(R hi23
v& ( 5 676 N 89: N
8# $' '(U8WX# vc < -$4 89:
-hi$ w #vb' ." x $
89:w
yHT V 4
89:w yHTBC R i23' 32 z {
."12 4 $ P 5 = B P # L(R &Q$ |!"
() B Oo }L # m j' 1(Cx STU #
~ # & 6 $ L 21(b'
+,- # ] , 4gt( -12
L[ISTU# $' ] , 4 P () B Oo
@3' }L (C 312< N
4 W l e 4kl -C hi23 &1&
2 BC @3' # Bc(] , Bb P N f & L # R3 ."
- )432 $ B R L @3 ] ,-$4 ] ,# 4 >?46D ] , ¡ 32 4 O #¢ &C 4 ^( £ ¤2w >?-
$ (U[U¥¦§4 BC¨ $
¡8HIªG« BC @3 ©
." @3 ¬R¬R4#L 4 < M'Bc BC R Bc( e- 4 L N 4 P ®Oq¯° # c
5 e ± 4 d&< -²c³ 4´ # LM(°²
&($ j' 9O 4 |L - c1 34$($4 'm4 ° µJ
$4 O 4 |&($ B < P B < &4$
6 4 ] , ¶ ($- 4 ·/ g$ ¸
¹ dL & § - &1& O$g$) ; ( ] ,# &'[ISTU# &' # b$4;- ªX6« |P6TªX
# &' 4 N BCV @3 6ºT ¹» && $c ^23' ' .OL BC ¼ # LBc (b' ³½ >?
& @3 V # L cm)(' k e C#L1 &
!" # $
# % & ' ( )
* + ,- (
. / 01 2 3 4
5 6 789 : ; + < = >? @
A + BA &
5 6 789 C D E F <
!GBAH IHJ K6 LM N OP 2
Q RP S & = )
T $' UVWX ! @ !
; Y6 Z[ @ \
]^ _ `
]^
(a @
]^ b )
F
$ & \ H cd = d # e
fW Ag EGh i & = )
BA j k l m
no N J p + BA BA 6
; + B $ & Ag EGh
A BA !GBA q
r s t uvw xy A z F
{ LM + BA $ & !|
/ 6 }~ OP t WX J p 6 A
$ t
, + dp + i . F l + BA dp dp - % d (
' dp b
dp N J
dp = BAH $
dp OP !| N H U =X
F LM N ` ;H k
OP % e
% e H
l + LM
uN k LM - ? Z J
+ i e
! ( ¡
¢£¤ LM ¥ ¦ § ¨ |
J ( ) ©ª
!"#$
% & ' (
῍
ῌ
,
DNA J B /HSP B , bromodomain contain- MazF
ing brd C SEC -like a SEC L a HIV in vitro
C HIV PBMCs, CD
siRNA shRNA cDNA T MazF
HIV X R R X
cDNA HIV
T MazF
cDNA
HIV
HIV HIV
HIV mRNA
HIV ACA
HIV
cDNA HIV CD T MazF
CD T
MazF CD T
HIV CD T
MazF
HIV HIV
HAART
HIV
Tat RNA MazF
HIV HAART
HIV MazF
mRNA ACA HIV
RNA HAART
HIV
ATP
MazF HIV
mRNA
rRNA tRNA DNA ACA
DNA
RNA prevention eradication
HIV ACA HIV robustness
TAR MazF
HIV eradication
Tat TAR MazF
HIV mRNA HIV eradi-
RNA MazF
+/ +0
0 .* 0
. . +. + +. +
.
. / / .
.
. 0*
.
.
/
,.*
.
13 ,+
ῌ
῍ ῌ
ῌ
ῌ
ῌ ῌ
ῌ
ῌ
ῌ
ῌ ῌ
ῌ ῌ
ῌ
ῌ
ῌ
ῌ Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy
macrophage-tropic HIV- . Science : , .
MW, Allikmets R, Goedert JJ, Buchbinder SP, Vittingho
transmembrane, G protein-coupled receptor. Science :
Urano E, Ichikawa R, Morikawa Y, Yoshida T, Koyanagi
Zhang Y, Zhang J, Hoeflich KP, Ikura M, Qinq G, Inouye M : MazF cleavages cellular mRNAs specifically at ACA AS : Genome-scale RNAi screen for host factors required
for HIV replication. Cell Host Microbe : , .
into the mRNA cleavage mechanism by MazF, an mRNA late early-stage HIV- replication. Cell : , .
cation Miraglia LJ, Bushman FD, Young JA, Chanda SK :
Global analysis of host-pathogen interactions that regu-
Go SP : Knockdown screens to knockout HIV- . Cell
: , .
PE, Murphy PM, Berger EA : CC CKR : a RANTES, Ishikawa H, Barber GN : STING is an endoplasmic re- MIP- alpha, MIP- beta receptor as a fusion cofactor for ticulum adaptor that facilitates innate immune signalling.
Nature : , .
Dean M, Carrington M, Winkler C, Huttley GA, Smith Ishikawa H, Ma Z, Barber GN : STING regulates in- tracellular DNA-mediated, type I interferon-dependent E, Gomperts E, Donfield S, Vlahov D, Kaslow R, Saah innate immunity. Nature : , .
A, Rinaldo C, Detels R, O’Brien SJ : Genetic restriction Feng Y, Broder CC, Kennedy PE, Berger EA : HIV- of HIV- infection and progression to AIDS by a de- entry cofactor : functional cDNA cloning of a seven- letion allele of the CKR structural gene. Hemophilia
Growth and Development Study, Multicenter AIDS , .
Cohort Study, Multicenter Hemophilia Cohort Study, Valente ST, Go SP : Inhibition of HIV- gene expres- San Francisco City Cohort, ALIVE Study. Science : sion by a fragment of hnRNP U. Mol Cell : ,
, . .
Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus Urano E, Kariya Y, Futahashi Y, Ichikawa R, Hamatake E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Fukazawa H, Morikawa Y, Yoshida T, Koyanagi Y, M, Montana JB, McHale M, Sullivan J, Ridgway C, Yamamoto N, Komano J : Identification of the P-TEFb Felstead S, Dunne MW, van der Ryst E, Mayer H : complex-interacting domain of Brd as an inhibitor of Maraviroc for previously treated patients with R HIV- HIV- replication by functional cDNA library screening
infection. N Engl J Med : , . in MT- cells. FEBS Lett : , .
Karn J : Tackling Tat. J Mol Biol : , .
Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman T, Komano J : T cell-based functional cDNA library A, Xavier RJ, Lieberman J, Elledge SJ : Identification of screening identified SEC -like a carboxy-terminal do- host proteins required for HIV infection through a func- main as a negative regulator of human immunodeficiency tional genomic screen. Science : , . virus replication. Vaccine, in press.
Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth
to block protein synthesis in Escherichia coli. Mol Cell
: , .
Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy Zhang Y, Zhang J, Hara H, Kato I, Inouye M : Insights GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley
CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, interferase. J Biol Chem : , . Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP,
+ ,1, +3// +3/2 +330
#
,1,
. .3/ /*. ,**2
+ +-/ .3 0* ,**2
2 # +
+ +-/ .+1 .,* ,**2
/ 3
+ +
.// 01. 012 ,**2
, +*
.0+ 122 13, ,**3
++ +
+
/
21, 211 +330
+, # +
,1- ,- /31 0*/
+2/0 +20, +330 ,**0
- +-
.
/ +
+ -/3 +.,3 +..+ ,**2 . /2, .*/- .*/2 ,**2
. ,3- ,-/ ,/. +333 +.
/
+. +
-+3 3,+ 3,0 ,**2
0 +/
+, 3+- 3,- ,**-
1 +0
,2* -+.* -+/* ,**/
